Keyphrases
Adenosine Dialdehyde
20%
B16 Melanoma
40%
B16 Melanoma Cells
20%
Cancer Treatment
20%
Complex Presentations
20%
Cross-linker
20%
Cycloheximide
20%
Cytokine Therapy
20%
Hydrostatic Pressure
100%
Immunogenic
40%
Immunogenic Tumor
20%
In Vitro Sensitization Assay
20%
Interferon-α (IFN-α)
20%
Major Histocompatibility
100%
Major Histocompatibility Complex
100%
Major Histocompatibility Complex Molecules
20%
Melanoma Cells
20%
Protein Cross-linking
20%
Protein Synthesis
20%
Sequential Treatment
40%
Surface Projection
100%
Therapeutic Vaccine
40%
Tumor Cells
20%
Tumor Necrosis Factor-α
20%
Immunology and Microbiology
Cross Linking
100%
Cytokine
100%
Histocompatibility
100%
Hydrostatic Pressure
100%
Immunotherapy
16%
interferon
16%
Major Histocompatibility Complex
100%
Melanoma Cell
33%
Protein Synthesis
16%
Sensitization
16%
Tumor Cell
16%
Tumor Necrosis Factor
16%
Tumor Vaccine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Dialdehyde
16%
Cycloheximide
16%
Cytokine
100%
Immunotherapy
16%
Interferon
16%
Malignant Neoplasm
16%
Melanoma
16%
Melanoma B16
33%
Neoplasm
16%
Tumor Necrosis Factor
16%
Tumor Vaccine
33%
Neuroscience
Adenosine Dialdehyde
16%
Cycloheximide
16%
Immunotherapy
16%
In Vitro
16%
Interferon
16%
Major Histocompatibility Complex
100%
Necrosis
16%
Protein Biosynthesis
16%
Tumor Vaccine
33%